USANA Health Sciences Shareholders: Ownership Structure, Brands, and Acquisition History
Last updated: October 2026Ownership Structure
Ownership Analysis
Gull Global’s 40.1% beneficial stake gives USANA a founder-linked center of influence.. The 2026 proxy also reports Vanguard at 5.1%, while June 13F data identifies BlackRock, Pzena, Renaissance, and other institutions as significant holders. These institutions can influence governance, but none appears positioned to displace the founder-linked block through ordinary trading. That gives the company strategic continuity and may support investments that require more than one quarter to mature. It also raises the bar for board independence: directors must be able to challenge management and the controlling holder when acquisitions, impairment decisions, or capital allocation do not meet return thresholds. The latest quarter tests whether the new portfolio can support the legacy business. Sales fell 5% to $223 million, core active customers declined to 384,000, Hiya subscribers fell to 166,000, and the reported loss included a $29.1 million preliminary impairment. Cash of $169 million and zero debt preserve flexibility, but liquidity does not make a weak acquisition automatically attractive. Board disclosure should compare Hiya and Rise with their original investment cases, including acquisition cost, churn, contribution margin, and channel economics. Founder control can shelter a credible transformation from short-term pressure, yet it can also weaken accountability if minority shareholders lack a practical path to change. Independent director leadership and transparent related-party review are therefore essential. Compensation should reward customer retention, sustainable earnings, and cash conversion rather than sales growth alone. The structure is defensible if the founder’s long horizon remains coupled with rigorous oversight. Investors should track whether the business narrows its losses and stabilizes active users, not merely whether product launches and acquisitions enlarge the catalog. An effective review would involve directors who are not dependent on the founder-linked holder and who can test assumptions about affiliate relationships, executive pay, and additional capital commitments.
Direct Owners
Institutional Shareholders
Shareholder Analysis
USANA’s shareholders include one large founder-associated block and a broad set of institutional investors.. Gull Global reported 40.1% in the 2026 proxy, while June 30 13F filings list BlackRock at 8.5%, Pzena at 6.6%, Renaissance Technologies at 5.2%, Dimensional at 4.6%, and Nantahala at 4.4%. These 13F positions represent managers’ reported long holdings and can overlap with other filings; they are not a clean allocation of all shares. The proxy’s March record date and quarterly institutional reports also differ in timing. Taken together, the sources indicate that outside institutions have a credible voice but do not form a controlling bloc. That register composition changes how governance pressure is likely to work. Activists would face a substantial founder-linked position, while institutional engagement on board independence, pay, and capital use remains possible. Weak operating results make that scrutiny more urgent. Core active customers contracted as sales fell to $223 million in the latest quarter, and a non-cash impairment contributed to a $21.4 million net loss. At the same time, cash and zero debt preserve choices between investing in acquired brands, rebuilding the associate network, and repurchasing shares. The board should explain why each deployment of cash offers a stronger expected return than the available alternatives. The founder’s historical ownership can support mission continuity, but minority investors should still receive transparent segment reporting and acquisition scorecards. Institutional holders should evaluate management against retention, customer economics, and gross margin rather than accept broad references to omnichannel growth. The register provides stability but also a clear asymmetry: one block has lasting influence, while other holders must coordinate to change outcomes. Strong independent oversight is what makes that asymmetry compatible with public-market accountability.
Brands, Subsidiaries & Companies Owned
| Name | Type | Description |
|---|---|---|
| USANA Nutritionals | Brand | Vitamins, minerals, supplements, and targeted nutritional products sold through direct selling |
| USANA Foods | Brand | Low-glycemic meal replacement shakes, snack bars, and nutritional foods |
| Hiya Health | Subsidiary | Children’s wellness and direct-to-consumer nutrition brand in which USANA owns a 78.8% controlling stake |
| Rise Wellness | Subsidiary | Wellness portfolio acquired to extend into modern functional nutrition |
| CellSentials | Brand | Daily foundational multivitamin and mineral system |
| USANA Skincare | Brand | Personal-care and skincare products sold through the global direct-selling network |
Portfolio Analysis
Different routes to market now sit beside the original USANA associate-led supplement business.. The original USANA nutrition and skincare lines rely heavily on direct selling through associates and preferred customers. The model can create personal education and repeat purchasing, but it also depends on associate productivity, recruitment, and the appeal of the compensation opportunity. Hiya Health uses a direct-to-consumer model for children’s vitamins and related products, while Rise Wellness addresses newer functional nutrition consumers. These brands expand demographic reach and diversify distribution, but their digital marketing and subscription economics differ sharply from a global associate network. The FY2025 product mix remained centered on nutritionals, which represented 71% of product sales, with essentials, foods, skincare, and other products making up the balance. Customer and subscriber counts in the latest quarter weakened across both the legacy and acquired businesses: core nutrition had 384,000 active customers, Hiya 166,000 subscribers, and Rise faced a packaging disruption. Those figures make brand-level reporting more valuable than a single consolidated sales line. Repeat purchase, customer acquisition cost, product returns, and channel-level margins will show whether the brand portfolio is earning its capital. USANA’s in-house manufacturing can support quality control and supply reliability, though fixed facilities need sufficient throughput to remain economical. CellSentials and foundational nutrition may support recurring use, while specialist products can raise basket size; cross-selling should be demonstrated rather than assumed. The brands make strategic sense if they let the company serve different ages and purchasing preferences without diluting product credibility. The risk is that each new identity consumes marketing capital while the associate base is shrinking. Management should explain how product claims are substantiated and how acquired businesses fit the same standards. Portfolio breadth is not inherently an advantage; the decisive measure is durable customer value and profitable retention across distinct channels.
Market Share & Competitors
| Company | Market Share | Revenue | Key Strength |
|---|---|---|---|
| USANA Health Sciences ★ | 11.4% | $925M | Established direct-selling network with in-house manufacturing |
| Herbalife | 61.8% | $5.0B | Global nutrition distribution network and recognized shake products |
| Nu Skin | 21.0% | $1.7B | Direct-selling infrastructure across beauty and wellness categories |
| Nature’s Sunshine | 5.8% | $470M | Herbal supplement expertise and international direct sales |
Competitive Analysis
Nutrition companies compete on repeat use, product evidence, distribution productivity, and consumer trust.. Its historic advantage is a global direct-selling network combined with in-house manufacturing. Herbalife uses a comparable distribution model at greater scale, while Nu Skin combines wellness and personal care, and Nature’s Sunshine has a long history in herbal supplements. Digital-first brands such as Hiya face a different set of competitors, including pediatric wellness companies that acquire customers online and through retail. The chart percentages compare the selected issuers’ reported revenue within a peer set; they are not measured shares of vitamins, supplements, or children’s wellness spending. USANA’s $925 million 2025 sales put it below the largest global peers, and Q2 2026 performance underscores that scale alone will not restore momentum. Core active customers fell 8% year over year to 384,000. Hiya’s subscribers fell to 166,000 as the digital marketing environment pressured acquisition and retention. The competitive test therefore differs by channel. Associates must offer product trust and an attractive business proposition; DTC customers require convenient subscriptions and efficient acquisition costs; retailers need dependable velocity and margin. Customer retention, order frequency, associate productivity, gross margin, and compliance by brand deserve close scrutiny. In-house manufacturing may help control quality and inventory, but it does not guarantee a cost advantage if plant utilization declines. Product claims also carry reputational and legal risk in a market crowded with health promises. USANA can distinguish itself through evidence-supported formulations and consistent quality, but the company must show consumers why products merit a premium. The current portfolio offers several routes to growth, though weaker customer trends make it prudent to assess each on its own economics. Long-term competitive strength will come from trusted outcomes and repeat demand, not from simply adding brands or geographies.
Acquisitions
| Company Acquired | Deal Value | Year | Description |
|---|---|---|---|
| Hiya Health Products | $205M | 2024 | Acquired a 78.8% controlling stake in the children’s wellness company |
| Rise Wellness | undisclosed | 2025 | Acquired to add functional nutrition products and reach younger consumers |
Acquisitions Analysis
The $205 million Hiya transaction was a material departure from USANA’s historically organic growth.. It brought a fast-growing children’s wellness brand with a direct-to-consumer subscription model, a customer segment younger than the company’s traditional associate base, and a different route to market. Acquiring Rise Wellness in 2025 extended the same diversification thesis into functional nutrition, although the purchase consideration was not disclosed. These assets broaden the addressable market, but their performance has become more challenging. Hiya contributed $28 million in the latest quarter, down 17%, as monthly subscribers declined 17% to 166,000. Rise generated $3 million and faced a packaging disruption during the quarter. USANA also recorded a preliminary $29.1 million non-cash impairment, signaling that management revised assumptions about at least part of the portfolio’s expected value. The impairment does not prove the acquisition failed, but it makes original underwriting and subsequent operating metrics central to shareholder assessment. Brand-level gross margins, retention cohorts, acquisition costs, and repeat-order contribution should be disclosed. The 21.2% noncontrolling interest in Hiya also means USANA does not capture every dollar of the subsidiary’s earnings. That should be reflected when management presents consolidated returns. These acquisitions are strategically adjacent, but cultural integration and channel economics are not automatic. Direct selling depends on human relationships, whereas DTC growth often depends on paid media and subscription retention. The board should prevent the company from allocating capital based on category enthusiasm alone. A clear post-acquisition review should compare cash invested with current customer economics and expected future contribution. Additional spending makes sense only where it raises the probability of sustainable, profitable growth. The lesson is not to abandon diversification; it is to require stronger evidence before committing additional capital.
Acquisition Timeline
Merger & Spin-off History
Merger & Spin-off Analysis
For most of its history, USANA expanded through its own network rather than large acquisitions.. Founded in 1992 by Myron Wentz, the company built a direct-selling network and expanded internationally while remaining listed on the NYSE. The Hiya acquisition brought a direct-to-consumer children’s wellness business, adding a new age cohort and a subscription-led channel. Rise Wellness extended the company into functional nutrition. Neither deal was a merger of equals, and USANA retained control, so the integration challenge is primarily operational: connect product development, supply chain, regulatory review, and brand management while leaving each route to market appropriate to its customer. The transactions represent a strategic bet that diversification can offset stagnation in the legacy associate base. Early results require caution. The latest period brought lower core customer counts, weaker Hiya subscriptions and sales, a Rise packaging issue, and an impairment charge. That cluster suggests integration and execution are not yet producing the balanced growth thesis management sought. A reported impairment should trigger a transparent reassessment of the cash flows and cost assumptions embedded in the acquisition values. Management must show whether the setback is operational or whether the acquisition thesis itself was flawed. Brand autonomy can preserve a DTC business’s digital identity; shared manufacturing or data capabilities may still create efficiencies. The board should monitor whether those benefits are actually captured. USANA’s prior history provides limited precedent for absorbing businesses with different channels, making the next several quarters unusually informative. Retention, contribution margin, and cross-selling milestones should precede any further acquisition. The acquisitions can give the company relevance with new consumers, but only if the combined group improves customer economics instead of using parent cash to subsidize persistent losses. This outcome differs from a successful integration, which would be visible in recurring customer cohorts and margin improvement. Reduced growth expectations need to be incorporated into future capital decisions.
Ownership History
Ownership History Analysis
Myron W. Wentz founded USANA in 1992, and a vehicle associated with him still holds a significant block.. Wentz, and remains shaped by the large block held through Gull Global. After its 1992 founding, USANA developed nutritional products and direct-sales distribution before listing publicly in 1996 to support expansion. Public-market access financed manufacturing, international growth, and the company’s continued product development, while the founder-linked stake preserved meaningful influence. The 2026 proxy reports Gull Global at 40.1%, with institutional investors such as Vanguard, BlackRock, and Pzena owning smaller positions. That concentration has persisted through strategic changes and gives USANA a more stable voting base than many consumer health companies. It also means minority investors depend heavily on board independence and the quality of disclosure. For much of its history the operating model centered on supplements sold through associates; the recent acquisition of Hiya and addition of Rise represent a change in direction, not a gradual extension of the same channel. Against $925 million of 2025 revenue, the latest sales decline shows that this evolution is occurring under pressure. A founder-influenced register can be an advantage if it supports a patient transformation, especially when customer habits and distribution systems take time to rebuild. However, sustained influence can also make it harder for the market to enforce a change in capital allocation. The board’s review of the 2026 impairment should explain how weaker customer metrics changed its assumptions. The key question is whether public capital remains committed to a focused health-products company or subsidizes a collection of unrelated consumer ventures. Ownership history matters directly to future value: stable control can protect strategy, but progress still requires measurable milestones and independent review.
Ownership Explained
USANA Health Sciences is publicly listed, but its ownership is not broadly dispersed. The 2026 proxy identifies Gull Global, Ltd. as beneficial owner of 40.1% of the common stock, with Vanguard at 5.1% on the proxy’s record date. SEC filings associate the Gull Global position with the company’s founder, Myron W. Wentz. This concentrated block gives the founder-linked vehicle meaningful influence over shareholder votes, while the remaining shares trade publicly and are held by institutions and other investors. Recent June 2026 13F filings show BlackRock, Pzena Investment Management, Renaissance Technologies, Dimensional, and Nantahala among the larger reported institutional positions. Because the proxy and portfolio filings use different dates and rules, these figures should not be added as if they formed a complete contemporaneous register. Founded in Salt Lake City in 1992, USANA built its original business around nutritional supplements sold through independent associates and preferred customers. Its portfolio now spans nutrition, personal care, children’s wellness, and functional nutrition. It acquired a 78.8% controlling interest in Hiya Health in December 2024 for $205 million and later added Rise Wellness. Those subsidiaries extend the company beyond its traditional customer base, while USANA retains operating control. The group reported $925 million in 2025 sales and employed about 1,570 people. June-quarter sales were $223 million, down 5%, while the company recorded a $21.4 million loss that included a $29.1 million preliminary non-cash impairment. The financial pressure makes ownership influence especially consequential: capital allocation and turnaround choices will determine whether the newer ventures complement the legacy direct-selling network. This is a founder-linked public company, not a fully dispersed consumer-products issuer, and its governance should be assessed accordingly. This arrangement gives a founder-associated holder substantial influence, but the company’s 2026 proxy treats institutional positions separately and does not show a second party with comparable voting power.
The controlling influence associated with Gull Global means USANA’s strategic direction is less likely to change through a routine accumulation of public shares than at a widely held company. Customers, associates, and employees still deal with a public corporation whose board owes duties to all shareholders, but the founder-linked block can materially shape director elections and long-term priorities. This may help preserve a patient view of the brand and direct-selling network, yet it can also make independent oversight more important when results weaken. The business is in transition: USANA’s legacy supplements and skincare products are distributed through associates, while Hiya sells children’s wellness products directly to consumers and Rise Wellness adds newer functional nutrition. These channels reach different customers and depend on different marketing economics. The Q2 2026 report showed 384,000 core nutritional active customers, down from 418,000 a year earlier, and Hiya’s active monthly subscribers fell to 166,000 from 200,400. Alongside a $21.4 million net loss that included a non-cash impairment, USANA ended the quarter with $169 million in cash and no debt. For associates and employees, ownership continuity can provide time to adapt the model, but funding should follow evidence of customer retention and unit economics. Consumers benefit when product claims, manufacturing quality, and distribution are overseen consistently across acquired businesses. Investors need to see whether management can stabilize the core while building a profitable omnichannel portfolio. The board should separate founder influence from performance review, particularly when weighing new investment in acquired brands against returning capital. A 40.1% block creates stability but can reduce the threat of shareholder intervention. That makes independent directors, transparent impairment assumptions, and clear milestones for Hiya and Rise particularly valuable. The ownership structure can protect a long-term plan only if that plan is revised when customer data and cash returns require it.